PRA eyes double-digit growth in 2016 after a banner revenue year
PRA Health Sciences posted a solid set of financials for the fourth quarter as it predicts double-digit growth in the coming year.
Quintiles bets on a big 2016 as revenue rolls in
Quintiles, the world's largest CRO, is expecting its revenue to jump as much as 8.5% in 2016 on the heels of a record year. Read more >>
TOP HEADLINES
FEATURED STORY
Synexus buys Research Across America, gaining first access to the U.S.
The site management organization Synexus has strengthened its global reach with the acquisition of Research Across America, marking its arrival into the lucrative U.S. market.
Medpace signs on to help Actinium get its cancer drug into Phase III
CRO Medpace has signed a deal with Actinium Pharmaceuticals to push the drug developer's lead cancer treatment through late-stage development.
Chinese CRO R&G buys into Medidata's trial tech
R&G Pharma Studies, a Chinese CRO, is deepening its relationship with clinical trial tech provider Medidata, adopting the company's cloud-based management system.
PRA eyes double-digit growth in 2016 after a banner revenue year
PRA Health Sciences posted a solid set of financials for the fourth quarter as it predicts double-digit growth in the coming year.
Infinity taps CRO Pharm-Olam for a Phase II lymphoma study
Houston CRO Pharm-Olam is on board to help Infinity Pharmaceuticals get its in-development lymphoma therapy through a Phase II trial, recruiting 230 patients in hopes of demonstrating an effect on survival.
Synexus buys Research Across America, gaining first access to the U.S.
The site management organization Synexus has strengthened its global reach with the acquisition of Research Across America, marking its arrival into the lucrative U.S. market.
From Our Sister Sites
Johnson & Johnson and AbbVie have snagged the indication for standout cancer med Imbruvica that they've been waiting for.
Cambridge Cognition and Ctrl Group have teamed up to develop mental health-focused wearables. The initiative will tap into Cambridge Cognition's experience making software to test for depression, schizophrenia and dementia in an attempt to bring Fitbit-style monitoring to mental health.
POPULAR COMMENT THREADS